PharMerica CORP - FORM 10-K - EX-23.1 - CONSENT OF KPMG LLP - February 24, 2011

Attached files

file filename
10-K - FORM 10-K - PharMerica CORPd10k.htm
EX-32.2 - 906 CERTIFICATION OF THE CFO - PharMerica CORPdex322.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - PharMerica CORPdex211.htm
EX-31.1 - 302 CERTIFICATION OF THE CEO - PharMerica CORPdex311.htm
EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - PharMerica CORPdex232.htm
EX-31.2 - 302 CERTIFICATION OF THE CFO - PharMerica CORPdex312.htm
EX-32.1 - 906 CERTIFICATION OF THE CEO - PharMerica CORPdex321.htm
EX-10.40 - AMENDED AND RESTATED PRIME VENDOR AGREEMENT - PharMerica CORPdex1040.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors

PharMerica Corporation

We consent to the incorporation by reference in the Registration Statement on Form S-8 (333-145137) of PharMerica Corporation of our report dated February 24, 2011 with respect to the consolidated financial statements as of and for the year ended December 31, 2010 and the effectiveness of internal control over financial reporting as of December 31, 2010, which report appears in this Form 10-K.

/s/ KPMG LLP

Louisville, Kentucky

February 24, 2011

.

Stock widget

Investing forum

PharMerica CORP Reports

Also read